Veris Residential (VRE) Files Rule 144 Notice for 26,600 NYSE Shares

Rhea-AI Filing Summary

Veris Residential, Inc. (VRE) filed a Form 144 reporting a proposed sale of common stock. The notice covers 26,600 shares with an aggregate market value of $416,276.70, against 93,421,769 shares outstanding. The sale is scheduled to occur on or about 09/15/2025 on the NYSE. The filing shows the shares to be sold were acquired in open-market purchases on 11/20–11/21/2018 for an aggregate of 25,600 shares paid in cash. The form also lists multiple sales of common stock by related entities during September 2025 with specific dates, share amounts, and gross proceeds. The filer affirms no undisclosed material adverse information and includes the standard signature and legal attestation language.

Positive

• Proposed sale is fully documented: the notice specifies 26,600 shares, aggregate value $416,276.70, sale date 09/15/2025, and exchange NYSE.
• Acquisition history provided: shares were acquired in open-market purchases on 11/20–11/21/2018 and paid in cash, meeting Rule 144 disclosure requirements.
• Broker identified: Morgan Stanley Smith Barney LLC is named as the executing broker.

Negative

• Multiple recent sales reported: the filing lists several sizable common-stock sales by related entities during September 2025 with specific share counts and gross proceeds.
• Potential market supply increase: aggregated recent disposals (as listed) reflect meaningful share movements in early September 2025, though the filing does not quantify total percentage of float.

Insights

Securities Analyst

TL;DR: Routine Rule 144 sale notice for 26,600 VRE shares; recent related sales recorded in September 2025.

The filing is a standard Rule 144 notice indicating an intended sale of 26,600 common shares valued at $416,276.70 against 93,421,769 outstanding shares, to be executed on the NYSE on 09/15/2025. Acquisition records show these shares were bought in open-market transactions in November 2018 and paid in cash. The document also catalogs multiple transactions by related entities in early September 2025 with detailed share counts and gross proceeds. From a market-impact perspective the filing provides transparency on planned insider-related disposition but does not itself state changes to operations, earnings, or governance.

Compliance / Risk Analyst

TL;DR: Form 144 complies with disclosure requirements and contains attestations; several recent entity sales are documented.

The notice includes necessary acquisition details, payment method, sale date, broker information (Morgan Stanley Smith Barney LLC), and the seller representation denying undisclosed material adverse information. It documents prior open-market purchases from November 2018 and lists multiple sales by MIRELF-related entities in September 2025 with dates, amounts, and gross proceeds. The filing meets Rule 144 reporting elements and includes the required legal attestation, enabling review for any internal compliance follow-up but does not by itself indicate a regulatory issue.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	26600	416276.70	93421769	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/21/2018	Open Market Purchase	Open Market			25783	11/23/2018	Cash
Common	11/20/2018	Open Market Purchase	Open Market			817	11/22/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	79724	1272734.52
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	106897	1706531.26
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	114560	1840956.29
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	85440	1373003.71
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Veris Residential's (VRE) Form 144 report?

The Form 144 reports a proposed sale of 26,600 common shares valued at $416,276.70, planned on 09/15/2025 on the NYSE.

When and how were the shares being sold acquired?

The shares were acquired via open-market purchases on 11/20–11/21/2018 and payment was made in cash.

Which broker will handle the proposed sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY.

Does the filing disclose other recent sales of VRE shares?

Yes; the filing lists multiple common-stock sales by MIRELF-related entities in September 2025 with dates, share amounts, and gross proceeds.

How many shares outstanding does Veris Residential report in the filing?

The filing lists 93,421,769 shares outstanding.